Chile approves emergency use of vaccine made by China's Sinovac


SANTIAGO, Jan. 20 (Xinhua) -- The Public Health Institute of Chile (ISP) on Wednesday approved the emergency use of a vaccine against the novel coronavirus disease (COVID-19) developed by Chinese firm Sinovac Biotech.

"We obtained very good results regarding the manufacturing quality and the strains being developed in the manufacture of this vaccine. We are approving a safe and effective vaccine for the population," acting director of the ISP, Heriberto Garcia, said.

The vaccine "prevents hospitalizations and the severity of the disease," he added.

Some 680,740 people in Chile have so far tested positive for COVID-19 and 17,594 have died from the disease, according to the health ministry.

The Chinese vaccine has been tested since the end of 2020 on volunteers participating in a phase III clinical trial run by the Institute of Immunotherapy and Immunology at Pontifical Catholic University of Chile.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In World

New Zealand's Auckland starts second lockdown in month
Myanmar's U.N. ambassador vows to fight after junta fired him
Ten arrested in Barcelona as protests over jailed rapper turn violent
Biden says he will make announcement on Saudi Arabia on Monday
France reports 23,996 new COVID-19 cases, 186 deaths
Cuba approves animal welfare law after civil society pressure
Italy reports 280 coronavirus deaths on Saturday, 18,916 new cases
As Mexico's largest migrant camp empties, new tents spring up along border
Spanish government says all cattle on pariah ship should be killed
Analysis: U.S. seeks to put Saudi crown prince in his place - for now

Stories You'll Enjoy


Vouchers